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Abstract
The Menkes ATPase (MNK) has an essential role in the translocation of copper across cellular membranes. In a
complementary manner, the intracellular concentration of copper regulates the activity and cellular location of the ATPase
through its six homologous amino-terminal domains. The roles of the six amino-terminal domains in the activation and
cellular trafficking processes are unknown. Understanding the role of these domains relies on the development of an
understanding of their metal-binding properties and structural properties. The second conserved sub-domain of MNK was
over-expressed, purified and its copper-binding properties characterised. Reconstitution studies demonstrate that copper
binds to MNKr2 as Cu(I) with a stoichiometry of one copper per domain. This is the first direct evidence of copper-binding
to the MNK amino-terminal repeats. Circular dichroism studies suggest that the binding or loss of copper to MNKr2 does
not cause substantial changes to the secondary structure of the protein. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Menkes disease is an X-linked, recessive disorder
characterised by a de¢ciency of serum copper and
copper dependent enzymes. The Menkes protein
(MNK) consists of 1500 amino acid residues and
contains all of the characteristic elements of a P-
type ATPase; a phosphorylation domain, a phospha-
tase domain, an ATP-binding site and a trans-mem-
brane cation channel [1^3]. The P-type ATPases are
a family of membrane proteins that use an aspartyl
phosphate intermediate to transport cations (H,
Na, K, Ca2, Cu2, Cd2, Hg2) across both the
plasma membrane and other intracellular membranes
[4]. MNK shares signi¢cant sequence identity with
other prokaryotic and eukaryotic P-type ATPases
involved in the membrane transport of copper, cad-
mium, mercury and calcium [5^7]. It has strongest
homology with the copper-exporting ATPase de¢-
cient in Wilson’s disease [8]. In vivo studies have
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shown that MNK transcription and translation is
not regulated by extracellular levels of copper, but
the rate of copper e¥ux is increased on copper ex-
posure [9]. Increasing levels of extracellular copper
also causes the rapid translocation of MNK from
its position in the trans-Golgi network (TGN) to
the plasma membrane [10]. MNK is rapidly trans-
ported back to the TGN once levels of extracellular
copper have fallen. Signal mediated cycling between
the TGN and the plasma membrane has been de-
scribed for GLUT4 and other proteins [11]. The met-
alloregulatory mechanism responsible for the ap-
parent increase in the MNK activity and its
translocation to and from the TGN is not under-
stood.
The amino-terminal regulatory domain of the
Menkes protein, MNKr (residues 1^652), contains
six repeating modules (MNKr1^6), each of which
consists of approximately 70 amino acids residues
and each contains a -X-Met-X-Cys-X-X-Cys- met-
al-binding motif (where X is any amino acid). Cys-
X-X-Cys- pairs are also found in the well-character-
ised metallothioneins, ACE1 and AMT where the
thiolates are involved in the binding of copper(I)
ions in polymetallic clusters [12^16]. Aside from the
-Cys-X-X-Cys- sequences, there is no general homol-
ogy with the MNK modules. However, the modules
show signi¢cant sequence similarity to a number of
recently characterised proteins believed to be in-
volved in metal transfer, such as Atx1 [17] and
HAH1 [18] or detoxi¢cation, such as CopZ [19]
and MerP [20], as shown in Fig. 1. Collectively, these
proteins have been called copper chaperones [21].
The sequence similarity between these proteins sug-
gests that they will bind metals in a similar manner.
The three dimensional structure of the mercury-bind-
ing protein MerP has been elucidated by NMR [22],
con¢rming earlier studies [23] that indicate MerP (72
amino acid residues) consists of two K-helices and
four anti-parallel L-sheets arranged in a L1-K1-L2-
L3-K2-L4 global fold. The general nature of this fold
is also supported by the recent structural determina-
tion of the fourth module of the Menkes protein
(MNKr4) [24]. The metal-binding site in these pro-
teins (-X-Met-X-Cys-X-X-Cys-), homologous to that
observed in MNKr2, occurs on a £exible loop be-
tween K-helix 1 and L-sheet 2. The predicted sec-
ondary structure of MNKr2, presented in Fig. 2,
correlates well with the known [22] and predicted
secondary structure of MerP and the fourth module
of MNK. The similarity of the NMR determined and
the predicted secondary structure of MerP supports
the use of this prediction method. Atx1, CopZ and
HAH1 are also predicted to have a similar L-K-L-L-
K-L global fold to that found in MerP. The sequence
homologies and secondary structure alignments
(Figs. 1 and 2) and their correlation with the known
merP and MNKr4 structures argues strongly that
MNKr2, and the other ¢ve modules in MNKr, will
have similar structures. Conversely, it argues against
the proposition that the domains are 30 amino acid
residues in length [25]. Here we report the over-
Fig. 1. Sequence alignment of the Menkes protein sub-domains with other proteins containing the XMXCXXC motif. The residue
numbers are indicated as follows. Amino acid sequence of the six copper-binding sub-domains in the Menkes protein (MNKr1, 8^75;
MNKr2, 171^238; MNKr3, 277^344; MNKr4, 377^444; MNKr5, 488^555; MNKr6, 564^631), mercury binding protein MerP (Shi-
gella £exneri, 3^70), copper-binding transcriptional activator CopZ (E. hirae, 1^68), Atx1 (Saccharomyces cerevisiae, 4^71) and HAH1
(human homolog of Atx1, 1^68). The conserved XMXCXXC motif is boxed.
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expression of MNKr2, the second sub-unit of MNK,
in soluble form and characterisation of its copper-
binding properties.
2. Materials and methods
2.1. Sequence analysis
Protein databases were searched using the Basic
Local Alignment Search Tool (BLAST) with default
parameters through the Australian National Ge-
nomic Information Service. Secondary structure
analyses were made using the ‘Protein Predict’ pro-
gram available at the European Molecular Biology
Laboratory (EMBL) using default parameters [26].
2.2. Expression and puri¢cation of MNKr2
The sequence coding for the second sub-domain of
MNK (residues M165 to K246, inclusive) was ampli-
¢ed from pQE30-53/4 (supplied by Julian F.B. Mer-
cer) using the PCR reaction with primers designed to
create NcoI/BamHI restriction sites at the 5P and 3P
termini, respectively. The sticky-ended fragment was
subcloned into the pET29-a expression vector (No-
vagen) resulting in a fusion of MNKr2 and the S-Tag
which has a MKETAAAKPERNHMDSPDLGTL-
VPRGS sequence. The S-tag can be cleaved at an
adjacent thrombin site. An Escherichia coli
BL21(DE3) strain transformed with the recombinant
plasmid, pSMNKr2, was grown to an A595nm of 1.0
at 37‡C and protein expression was induced by addi-
tion of 1 mM isopropyl-B-D-thiogalactopyranoside.
Two and a half hours after the induction the cells
were harvested by a 20 min 4000Ug centrifugation at
4‡C. All subsequent steps in the puri¢cation were
performed, except where noted, at 4‡C. Cell wall
disruption was achieved by sonication of the pellet
from 5 l of culture in 100 ml Bu¡er A (100 mM
potassium phosphate pH 7.3, 2 mM dithiothreitol
(DTT), 150 mM NaCl) supplemented with lysozyme
(25 mg/ml), RNAse A (50 U), DNAse II (50 U) and
1 mM MgCl2. Cellular debris and insoluble material
was removed by centrifugation at 25 000Ug for 35
min and discarded. S-Tag-MNKr2 was precipitated
from the supernatant with a 40^85% (NH4)2SO4 cut.
The precipitate was recovered after centrifugation at
25 000Ug for 35 min and then resuspended in Bu¡er
A. The resuspended pellet was loaded onto a gel
¢ltration column (16 mmU60 cm Superdex 75, Phar-
macia) equilibrated in Bu¡er A. Fractions containing
S-Tag-MNKr2 were identi¢ed by Tris-Tricine SDS-
PAGE [27] and pooled. S-Tag-MNKr2 in the pooled
fractions was precipitated with a 0^85% (NH4)2SO4
cut. The precipitated protein was recovered by cen-
trifugation at 25 000Ug for 35 min and the pellet
resuspended in 50 mM Tris pH 7.5, 150 mM NaCl,
2.5 mM CaCl2. Thrombin (10 mg) was added and
the sample incubated for 2 h at 31‡C. EDTA, EGTA
and DTT were added to 5 mM ¢nal concentrations
and the sample incubated at 31‡C for a further 30
min. MNKr2 was precipitated with a 0^85%
(NH4)2SO4 cut and resuspended in elution bu¡er,
100 mM potassium phosphate pH 7.3, 2 mM DTT,
150 mM NaCl, 5 mM EDTA, 5 mM EGTA.
MNKr2, in the absence of the S-Tag, has an approx-
imate molecular weight of 9294 Da. The protein mix-
ture was loaded onto a gel ¢ltration column (16
mmU60 cm Superdex 30, Pharmacia) equilibrated
in the elution bu¡er. Fractions containing MNKr2
were identi¢ed by Tris-Tricine SDS-PAGE and
Fig. 2. Alignment of predicted MNKr2 secondary structure with other proteins containing the XMXCXXC motif. The conserved
XMXCXXC motif is underlined in the MNKr2 amino acid sequence to highlight its position in the predicted arrangement of second-
ary structure. ‘E’ represents L-sheet and ‘H’ represents K-helix. The secondary structures of these proteins were predicted using ‘Pro-
tein Predict’ at EMBL as described in Section 2. MerP(A), the secondary structure of MerP determined by NMR [22]. MerP(B) is the
predicted secondary structure of MerP.
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pooled. The MNKr2 pool was exchanged into 50
mM sodium acetate, pH 5.5, by ultra¢ltration and
applied to a 0.8 ml POROS HS20 cation exchange
column. The protein was eluted with a linear ten
column volume 0^0.4 M NaCl gradient in 50 mM
sodium acetate, pH 5.5. MNKr2 containing fractions
were identi¢ed by Tris-Tricine SDS^PAGE and
pooled. Samples to be later designated as ‘undena-
tured’ MNKr2 were taken at this point and stored at
370‡C.
2.3. Preparation of Apo-MNKr2 and Cu
reconstitution
The puri¢ed MNKr2 pool was concentrated by
ultra¢ltration to 2 ml and then brought to a ¢nal
concentration of 6 M guanidine HCl, 100 mM Tris
pH 7.9, 10 mM EDTA. DTT was added to a ¢nal
concentration of 150 mM and the protein was re-
duced at 37‡C for 2 h. The mixture was run on a
gel ¢ltration column (1.5U25 cm Sephadex G-25,
Pharmacia) equilibrated with 25 mM HCl, 150 mM
NaCl. The reduced MNKr2 was aliquoted under
anaerobic conditions and stored at 4‡C. Protein pu-
rity and concentration were determined by quantita-
tive amino acid analysis. The reduction state of the
MNKr2 was assessed by quantisation of the thiols
with the dithiodipyridine assay [28]. The Cu(I) stock
solution was stabilised as CuCl32 , prepared under
anaerobic conditions by dissolving CuCl in 0.1 M
HCl supplemented with 1 M NaCl. Copper reconsti-
tutions were performed on samples with a reduction
state s 95% as described previously for MT [29] and
ACE1 [12]. Brie£y, the reduced protein was mixed at
pH 2.0 with copper(I) and water prior to adjusting
the pH with an addition of bu¡er. All spectra were
recorded at 23‡C in anaerobically sealed screw-
topped £uorescence cuvettes (Spectrocell) containing
a total volume of 2 ml.
2.4. Protein characterisation
Quantitative amino acid analysis was performed
on a Beckman 6300 analyser after 24 h in vacuo
acid hydrolysis at 110‡C in 6 M HCl with 0.01%
phenol. Amino acid analysis, rather than indirect
staining in gels or colorimetric methods, was used
to determine the protein concentrations for stoichi-
ometry analysis. Similarly, the copper concentration
was determined by £ame atomic absorption spec-
troscopy (FAAS) using a Varian A-8875 series
AAS in preference to chemical analyses.
2.5. Spectroscopic analysis of Cu-MNKr2
Absorption spectra were recorded on a Cary U3
UV-Visible spectrophotometer. Circular dichroism
spectra were recorded using a JASCO J-715 at
23‡C. Apo-MNKr2, Cu(I)-MNKr2 and ‘undena-
tured’ MNKr2 samples were prepared for circular
dichroism analysis in 100 mM sodium acetate bu¡er
pH 5.5, 150 mM NaCl. Four circular dichroism spec-
tra were recorded for each sample between 190 and
250 nm and averaged for each sample.
3. Results
The pET29 system expression of MNKr2 as a fu-
sion with S-Tag yielded 5^10 mg of soluble protein
per litre of culture. Using the three-step puri¢cation
process soluble MNKr2 was puri¢ed (minus the S-
Tag) to homogeneity, as assessed by Tris-Tricine
Fig. 3. Tris-Tricine SDS-PAGE analysis of MNKr2 puri¢ca-
tion. Lane 1, protein size standards (value in kDa on left) ; lane
2, pre-induction culture; lane 3, post-induction culture; lane 4,
supernatant after sonication and centrifugation; lane 5, pooled
Superdex 75 fractions; lane 6, pooled Superdex 30 fractions
(after S-Tag cleavage); lane 7, pooled POROS HS20 fractions;
lane 8, protein size standards (as per lane 1). Proteins were
visualised with Coomassie blue.
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SDS-PAGE (Fig. 3) and amino acid analysis.
MNKr2 does not co-purify with stoichiometric
amounts of copper. Supplementation of the growth
media with 1 mM CuSO4 did not result in the incor-
poration of stoichiometric amounts of copper into
the S-Tag-MNKr2 fusion protein (data not shown).
Presumably E. coli copper export systems limit the
accumulation of copper in the cell. While the addi-
tion of copper to E. coli culture can enhance the
incorporation of copper into recombinant proteins,
MNKr2 does not appear to serve as an adequate
sink for the exogenous copper. A similar lack of
exogenous copper incorporation was observed during
the over-expression of recombinant ACE1 [12].
To determine the in vitro copper-binding stoichi-
ometry of MNKr2 the puri¢ed apo-protein was ti-
trated with Cu(I). The titrations were monitored by
UV-Visible absorption spectroscopy from 240 to 340
nm. Addition of Cu(I) results in electronic transitions
in the UV (near 254 nm) consistent with the forma-
tion of S-Cu(I) charge-transfer bands (Figs. 4 and 5)
analogous to those found in the metallothioneins [15]
and ACE1 [12]. The only available cysteine residues
in MNKr2 occur in the conserved -X-Met-X-Cys-X-
X-Cys- motif. The insets in Figs. 4 and 5 show the
increase in absorbance at 254 nm as a function of
mole equivalents of Cu(I) added.
The copper reconstitution of MNKr2, as moni-
tored at A254nm, in sodium acetate bu¡er was stable
to approximately 1 mole of Cu(I) per mole of
MNKr2 (Fig. 4, inset). Samples prepared with
more than 1.1 moles of Cu(I) per mole of MNKr2
in this bu¡er gave erratic spectra and showed evi-
dence of protein aggregation (data not shown).
This aggregation was observed in several titration
series and is most likely the result of non-speci¢c
binding of Cu(I) to ligands outside the thiolate bind-
ing site. Copper reconstitution experiments per-
formed in imidazole bu¡er also indicate a copper-
binding stoichiometry of one to one, with a an ap-
parent plateau at 1 mol equivalent, but the protein
was more stable to super-stoichiometric amounts of
copper (Fig. 5, inset). At stoichiometries above 1 mol
equivalent there was a very small increase in A254nm/
equivalent of copper. This increase is partially attrib-
utable to some aggregation as noted by the increase
in absorbance spectrum across the 240^320 nm
range. The protein does, however, stay in solution
between the stoichiometries or 1.1 to 1.6, whereas
samples prepared in acetate tended to precipitate in
this region. It is most likely that the formation of a
weak Cu(I)^imidazole complex inhibited the excess
Cu(I) from binding to MNKr2 non-speci¢cally. Sim-
Fig. 4. Copper reconstitution of apo-MNKr2 in sodium acetate
bu¡er (pH 5.5). Samples of apo-MNKr2 (20 nmol/ml) were ti-
trated anaerobically with increasing mole equivalents of Cu(I).
The pH of the copper/protein mixture was raised by the addi-
tion of bu¡er (¢nal conditions, 50 mM sodium acetate, pH 5.5,
150 mM NaCl). The UV-visible spectrum was recorded between
230 and 340 nm. The inset shows the increase in absorbance at
254 nm with the addition of Cu(I).
Fig. 5. Copper reconstitution of apo-MNKr2 in imidazole
bu¡er (pH 6.5). Samples of Apo MNKr2 (20 nmol/ml) were ti-
trated anaerobically with increasing mole equivalents of Cu(I).
The pH of the copper/protein mixture was raised by the addi-
tion of bu¡er (¢nal conditions, 50 mM imidazole, pH 6.5, 150
mM NaCl). The UV-Visible spectrum was recorded between
230 and 340 nm. The inset shows the increase in absorbance at
254 nm with the addition of Cu(I). Extrapolation from linear
regression (- - -).
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ilar titrations carried out in Cl3-free solutions with
Ag(I)acetate also suggest that only one metal binds
per module (data not shown). Ag(I), because it is
isoelectric with Cu(I), is frequently used as a spectral
probe of Cu(I)-binding sites.
Circular dichroism (CD) studies were performed
on MNKr2 to examine: (1) the e¡ect of copper-bind-
ing on the proteins’ secondary structure; and (2) the
e¡ects of reconstitution on the proteins secondary
structure. The CD spectra of undenatured apo-
MNKr2, reconstituted apo-MNKr2 and reconsti-
tuted Cu(I)-MNKr2 are presented in Fig. 6. The
data indicate that the denatured protein (6 M
GdHCl) readily refolds to form a native or native-
like conformation. This is consistent with the results
of refolding studies performed on the structurally
homologous protein, merP [30], that demonstrated
the complete reversibility of merP denaturation by
GdHCl (monitored by tyrosine £uorescence and el-
lipticity). The data also indicate that the binding of
Cu(I) does not markedly perturb the repetitive sec-
ondary structure (K-helices and L-sheets). The mini-
mal change in the secondary structure of MNKr2
upon copper-binding observed here is predicted
from the recently derived NMR structure of both
the apo and silver-substituted forms of MNKr4 [24]
4. Discussion
Characterisation of the copper binding properties
of the second metal-binding domain of the Menkes
protein indicates the module maximally binds 1 mol
equivalent copper(I) via cysteinyl sulphur ligands.
The oxidation state and ligand environment are the
critical features of the copper ions interactions with
the domain and ultimately the amino-terminal do-
mains role in the activation of the ATPase.
Titration of [Cu(I)Cl]3x into MNKr2 leads to the
formation of a charge-transfer band at 254 nm that
reaches a maximum at 1 mol equivalent (Figs. 4 and
5). Spectral and physical changes in the samples with
a mole ratio of greater than 1 Cu(I)/protein suggest
that additional metal ions may be incorporated non-
speci¢cally. Furthermore, the binding of copper does
not appear by circular dichroism analysis to disturb
the secondary structure (Fig. 6). This agrees with the
minimal changes in secondary structure observed in
MerP [22] and MNKr4 [24] when they accept metal
ions. MerP shows a 2.8% decrease in K-helical con-
tent in K-helix 1 when mercury binds and a tilting of
the K-helices with respect to the four-strand L-sheet.
The lack of substantial changes in the structure sug-
gests the sub-domains of the Menkes protein amino-
terminal region are poised to receive and donate
Cu(I).
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